Journal article · 2023 · Open access
Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy
Bioactive Materials, 27, 168–180 · Published 5 April 2023 · DOI 10.1016/j.bioactmat.2023.03.018
In brief
“Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy” is a 2023 journal article by Yun Chang and 10 co-authors, published in Bioactive Materials. OpenAlex counts 37 citations as of 21 November 2026, which puts it in the top 2% of works published in 2023 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Bioactive Materials.
- Citations
- 37
- Most cited in
- 2025 (13)
- Field-weighted impact
- 4.11
- References
- 76
- Authors
- 11
Abstract
Adoptive chimeric antigen receptor (CAR)-engineered natural killer (NK) cells have shown promise in treating various cancers. However, limited immunological memory and access to sufficient numbers of allogenic donor cells have hindered their broader preclinical and clinical applications. Here, we first assess eight different CAR constructs that use an anti-PD-L1 nanobody and/or universal anti-fluorescein (FITC) single-chain variable fragment (scFv) to enhance antigen-specific proliferation and anti-tumor cytotoxicity of NK-92 cells against heterogenous solid tumors. We next genetically engineer human pluripotent stem cells (hPSCs) with optimized CARs and differentiate them into functional dual CAR-NK cells. The tumor microenvironment responsive anti-PD-L1 CAR effectively promoted hPSC-NK cell proliferation and cytotoxicity through antigen-dependent activation of phosphorylated STAT3 (pSTAT3) and pSTAT5 signaling pathways via an intracellular truncated IL-2 receptor β-chain (ΔIL-2Rβ) and STAT3-binding tyrosine-X-X-glutamine (YXXQ) motif. Anti-tumor activities of PD-L1-induced memory-like hPSC-NK cells were further boosted by administering a FITC-folate bi-specific adapter that bridges between a programmable anti-FITC CAR and folate receptor alpha-expressing breast tumor cells. Collectively, our hPSC CAR-NK engineering platform is modular and could constitute a realistic strategy to manufacture off-the-shelf CAR-NK cells with immunological memory-like phenotype for targeted immunotherapy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Chang, Y., Jin, G., Luo, W., Luo, Q., Jung, J., Hummel, S. N., Torregrosa‐Allen, S. E., Elzey, B. D., Low, P. S., Lian, X. L., & Bao, X. (2023). Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Bioactive Materials, 27, 168–180. https://doi.org/10.1016/j.bioactmat.2023.03.018
MLA 9
Chang, Yun, et al. “Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy.” Bioactive Materials, vol. 27, 2023, pp. 168–180. https://doi.org/10.1016/j.bioactmat.2023.03.018.
Chicago
Chang, Yun, Gyuhyung Jin, Weichuan Luo, Qian Luo, Juhyung Jung, Sydney N. Hummel, Sandra E Torregrosa‐Allen, et al. 2023. “Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy.” Bioactive Materials 27: 168–180. https://doi.org/10.1016/j.bioactmat.2023.03.018.
Harvard
Chang, Y. et al. (2023) ‘Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy’, Bioactive Materials, 27, pp. 168–180. doi:10.1016/j.bioactmat.2023.03.018.
IEEE
Y. Chang et al., “Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy,” Bioactive Materials, vol. 27, pp. 168–180, 2023, doi: 10.1016/j.bioactmat.2023.03.018.
BibTeX
@article{chang2023engineered,
title = {{Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy}},
author = {Chang, Yun and Jin, Gyuhyung and Luo, Weichuan and Luo, Qian and Jung, Juhyung and Hummel, Sydney N. and Torregrosa‐Allen, Sandra E and Elzey, Bennett D. and Low, Philip Stewart and Lian, Xiaojun Lance and Bao, Xiaoping},
journal = {Bioactive Materials},
year = {2023},
volume = {27},
pages = {168--180},
doi = {10.1016/j.bioactmat.2023.03.018},
url = {https://doi.org/10.1016/j.bioactmat.2023.03.018}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 8 | |
| 2024 | 8 | |
| 2025 | 13 | |
| 2026 | 8 |
Its field-weighted citation impact is 4.11: it has been cited 4.11 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- human pluripotent stem cells
- PD-L1
- immunological memory
- STAT3 signaling
- STAT5 signaling
- folate receptor alpha
- breast cancer
- adoptive immunotherapy
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Chang, Y., Jin, G., Luo, W., Luo, Q., Jung, J., Hummel, S. N., Torregrosa‐Allen, S. E., Elzey, B. D., Low, P. S., Lian, X. L., & Bao, X. (2023). Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Bioactive Materials, 27, 168–180. https://doi.org/10.1016/j.bioactmat.2023.03.018
How many times has this paper been cited?
37 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Bioactive Materials: sign in and open the full text from this page.
Who wrote this paper?
Yun Chang, Gyuhyung Jin, Weichuan Luo, Qian Luo, Juhyung Jung, Sydney N. Hummel, Sandra E Torregrosa‐Allen, Bennett D. Elzey, Philip Stewart Low, Xiaojun Lance Lian, Xiaoping Bao.
What is the DOI of this paper?
10.1016/j.bioactmat.2023.03.018, permanently at https://doi.org/10.1016/j.bioactmat.2023.03.018. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.